Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:2337-2338
Published online before print October 20, 2005, doi: 10.1161/01.STR.0000185665.15738.60
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/11/2337    most recent
01.STR.0000185665.15738.60v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Lugt, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Lugt, A.

(Stroke. 2005;36:2337.)
© 2005 American Heart Association, Inc.


Editorials

From Case Study to Prospective Study

Aad van der Lugt, MD, PhD

From the Department of Radiology, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.

Correspondence to Aad van der Lugt, MD, PhD, Department of Radiology, Erasmus MC-University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. E-mail a.vanderlugt@erasmusmc.nl


Key Words: atherosclerosis • MRI


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

See related article, pages 2507–2516

Atherosclerosis remains a major cause of death in industrialized countries. Our understanding of the natural course of the disease and of the effects of intervention is mainly based on autopsy studies and on studies in animal models. This has primarily been because of the lack of good tools to image plaque components in vivo. Indeed, even in animal studies, analysis of plaque components has occurred for the most part ex vivo by histologic sections and dedicated staining techniques. In vivo visualization of the atherosclerotic plaque and its components (calcifications, fibrocellular tissue, lipid core, hemorrhage, and thrombus), particularly in humans, will further elucidate the disease process and the effect of various types of interventions, and subsequently will have important clinical implications.

The severity of stenosis in the carotid artery is a well-known predictor of cerebral infarction and is currently the main parameter used in deciding between carotid intervention (endarterectomy or stent placement) and pharmacologic intervention. Plaque morphology is considered an additional, independent predictor of cerebral infarction: plaques containing a necrotic lipid core covered by a thin fibrous cap (known as unstable or vulnerable plaque) are prone to rupture,1,2 releasing thromboembolic particles to the brain. Therefore, noninvasive, in vivo assessment of plaque components in the carotid artery would be useful in therapy determination.

Carotid stenosis of a severity that warrants surgical or endovascular treatment is found in 10 to 20% of all patients with transient ischemic attack (TIA) or ischemic stroke. Atrial fibrillation occurs in 5% . . . [Full Text of this Article]